Neurological & CognitiveResearch OnlyD

Adamax

Semax-family Analog

Nootropic research peptide in the Semax-family class; limited direct clinical evidence.

Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
Studies cited
3
Research grade
D
Experience
99

Overall check-ins

Activity
97

Trackers & reports

Overview

About Adamax

Nootropic research peptide in the Semax-family class; limited direct clinical evidence.

Category
Neurological & Cognitive
Regulatory status
Research Only
Also known as
Semax-family Analog
Self-reports
24

Community

What 24 users report

24 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 98% · Mixed 2% · Unfavorable overall 0%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Energy
171
Cognition
171

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Headache
4

Self-reported dose per injection

Median bucket: 0.6–1 mg · Most common: 0.2–0.4 mg

Reports span 0.2–2 mg

0.2–0.4 mg
59
0.4–0.6 mg
12
0.6–1 mg
50
1–2 mg
50

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 92% said they felt similar to their last entry, 8% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 180 days · Based on 24 repeat reporters

Research

Cited research (2)

PubMed

Semax, an analog of ACTH(4-7), regulates expression of immune response genes

Dmitrieva et al., 2013

Source
Wiki study page →

Tools

Explore more

Help

Frequently asked

What do PeptIQ users report about Adamax?

This page summarizes 24 anonymized self-reports from PeptIQ users who track Adamax, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.

How do side effects relate to overall experience for Adamax?

PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.

What research is cited for Adamax?

2 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.

Is Adamax safe to use?

This wiki does not assess safety or recommend use. Adamax is listed as Research Only. Consult a licensed clinician for personal medical decisions.

What are the purported benefits and uses of Adamax?

This wiki summarizes observational community reports and linked citations for Adamax. It does not assert therapeutic benefits. See the cited research list on this page and the educational profile for Adamax for study-level context — not medical advice.

What is the legal status of Adamax?

Adamax is listed in PeptIQ as Research Only. Regulatory status varies by jurisdiction and can change. This wiki does not provide legal advice; check current FDA and local rules and talk with a licensed clinician or counsel for personal decisions.

What are the known or theoretical side effects and risks of Adamax?

Safety data quality for Adamax varies widely by compound and study design. PeptIQ does not establish a risk profile here. Review primary literature, product labeling where applicable, and clinician guidance. Community self-reports are not a substitute for clinical evidence.

What is the current state of research on Adamax?

This page links 2 indexed sources for Adamax. Evidence maturity differs by application — some peptides have large human programs, others are mostly preclinical. Treat citation counts as literature volume, not proof of efficacy.